Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation.

Turban JL, King D, Carswell JM, Keuroghlian AS.

Pediatrics. 2020 Feb;145(2). pii: e20191725. doi: 10.1542/peds.2019-1725.

PMID:
31974216
2.

A Blueprint for Planning and Implementing a Transgender Health Program.

Morenz AM, Goldhammer H, Lambert CA, Hopwood R, Keuroghlian AS.

Ann Fam Med. 2020 Jan;18(1):73-79. doi: 10.1370/afm.2473.

3.

Association Between Recalled Exposure to Gender Identity Conversion Efforts and Psychological Distress and Suicide Attempts Among Transgender Adults.

Turban JL, Beckwith N, Reisner SL, Keuroghlian AS.

JAMA Psychiatry. 2019 Sep 11:1-9. doi: 10.1001/jamapsychiatry.2019.2285. [Epub ahead of print]

PMID:
31509158
4.

Distinguishing and Addressing Gender Minority Stress and Borderline Personality Symptoms.

Goldhammer H, Crall C, Keuroghlian AS.

Harv Rev Psychiatry. 2019 Sep/Oct;27(5):317-325. doi: 10.1097/HRP.0000000000000234.

PMID:
31490187
5.

What do we say about condoms in 2019?

Ard KL, Krakower DS, Keuroghlian AS.

Lancet HIV. 2020 Feb;7(2):e82-e83. doi: 10.1016/S2352-3018(19)30237-1. Epub 2019 Aug 28. No abstract available.

PMID:
31473168
6.

Psychological Attempts to Change a Person's Gender Identity From Transgender to Cisgender: Estimated Prevalence Across US States, 2015.

Turban JL, King D, Reisner SL, Keuroghlian AS.

Am J Public Health. 2019 Oct;109(10):1452-1454. doi: 10.2105/AJPH.2019.305237. Epub 2019 Aug 15.

PMID:
31415210
7.

Required Sexual Orientation and Gender Identity Reporting by US Health Centers: First-Year Data.

Grasso C, Goldhammer H, Funk D, King D, Reisner SL, Mayer KH, Keuroghlian AS.

Am J Public Health. 2019 Aug;109(8):1111-1118. doi: 10.2105/AJPH.2019.305130. Epub 2019 Jun 20.

PMID:
31219717
8.

Meeting the Behavioral Health Needs of LGBT Older Adults.

Goldhammer H, Krinsky L, Keuroghlian AS.

J Am Geriatr Soc. 2019 Aug;67(8):1565-1570. doi: 10.1111/jgs.15974. Epub 2019 May 29.

PMID:
31140592
9.

Understanding and treating opioid use disorders in lesbian, gay, bisexual, transgender, and queer populations.

Girouard MP, Goldhammer H, Keuroghlian AS.

Subst Abus. 2019;40(3):335-339. doi: 10.1080/08897077.2018.1544963. Epub 2019 Feb 13.

PMID:
30759045
10.

Psychiatric Epidemiology of Transgender and Nonbinary Adult Patients at an Urban Health Center.

Beckwith N, McDowell MJ, Reisner SL, Zaslow S, Weiss RD, Mayer KH, Keuroghlian AS.

LGBT Health. 2019 Feb/Mar;6(2):51-61. doi: 10.1089/lgbt.2018.0136. Epub 2019 Feb 1.

11.

Training in Sexual and Gender Minority Health - Expanding Education to Reach All Clinicians.

Ard KL, Keuroghlian AS.

N Engl J Med. 2018 Dec 20;379(25):2388-2391. doi: 10.1056/NEJMp1810522. No abstract available.

PMID:
30575482
12.

Addressing Eating Disorders and Body Dissatisfaction in Sexual and Gender Minority Youth.

Goldhammer HB, Maston ED, Keuroghlian AS.

Am J Prev Med. 2019 Feb;56(2):318-322. doi: 10.1016/j.amepre.2018.09.011. Epub 2018 Dec 13. No abstract available.

PMID:
30554976
13.

Planning and implementing sexual orientation and gender identity data collection in electronic health records.

Grasso C, McDowell MJ, Goldhammer H, Keuroghlian AS.

J Am Med Inform Assoc. 2019 Jan 1;26(1):66-70. doi: 10.1093/jamia/ocy137.

14.

Communicating With Patients Who Have Nonbinary Gender Identities.

Goldhammer H, Malina S, Keuroghlian AS.

Ann Fam Med. 2018 Nov;16(6):559-562. doi: 10.1370/afm.2321.

15.

National Findings from an LGBT Healthcare Organizational Needs Assessment.

Goldhammer H, Maston ED, Kissock LA, Davis JA, Keuroghlian AS.

LGBT Health. 2018 Nov/Dec;5(8):461-468. doi: 10.1089/lgbt.2018.0118. Epub 2018 Nov 7.

PMID:
30383473
16.

Affirming Gender Identity of Patients With Serious Mental Illness.

Smith WB, Goldhammer H, Keuroghlian AS.

Psychiatr Serv. 2019 Jan 1;70(1):65-67. doi: 10.1176/appi.ps.201800232. Epub 2018 Oct 18.

PMID:
30332928
17.

Facilitators of and barriers to high-resolution anoscopy adherence among men who have sex with men: a qualitative study.

Apaydin KZ, Nguyen A, Panther L, Shtasel DL, Dale SK, Borba CPC, Lathan CS, Mayer K, Keuroghlian AS.

Sex Health. 2018 Nov;15(5):431-440. doi: 10.1071/SH18029.

PMID:
30244691
18.

Understanding Pediatric Patients Who Discontinue Gender-Affirming Hormonal Interventions.

Turban JL, Carswell J, Keuroghlian AS.

JAMA Pediatr. 2018 Oct 1;172(10):903-904. doi: 10.1001/jamapediatrics.2018.1817. No abstract available.

PMID:
30178056
19.

Public Health Detailing for Human Immunodeficiency Virus Pre-exposure Prophylaxis.

Ard KL, Edelstein ZR, Bolduc P, Daskalakis D, Gandhi AD, Krakower DS, Myers JE, Keuroghlian AS.

Clin Infect Dis. 2019 Feb 15;68(5):860-864. doi: 10.1093/cid/ciy573.

PMID:
30020422
20.

Three-dose HPV vaccine completion among sexual and gender minority young adults at a Boston community health center.

Apaydin KZ, Fontenot HB, Borba CPC, Shtasel DL, Ulery S, Mayer KH, Keuroghlian AS.

Vaccine. 2018 Aug 6;36(32 Pt B):4897-4903. doi: 10.1016/j.vaccine.2018.06.057. Epub 2018 Jul 5.

21.

Dynamic Gender Presentations: Understanding Transition and "De-Transition" Among Transgender Youth.

Turban JL, Keuroghlian AS.

J Am Acad Child Adolesc Psychiatry. 2018 Jul;57(7):451-453. doi: 10.1016/j.jaac.2018.03.016.

PMID:
29960687
22.

Factors associated with anal cancer screening follow-up by high-resolution anoscopy.

Apaydin KZ, Nguyen A, Borba CPC, Shtasel DL, Ulery S, Mayer KH, Keuroghlian AS.

Sex Transm Infect. 2019 Mar;95(2):83-86. doi: 10.1136/sextrans-2017-053515. Epub 2018 Jun 22.

PMID:
29934358
23.

Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center.

Apaydin KZ, Fontenot HB, Shtasel D, Dale SK, Borba CPC, Lathan CS, Panther L, Mayer KH, Keuroghlian AS.

Vaccine. 2018 Jun 18;36(26):3868-3875. doi: 10.1016/j.vaccine.2018.02.043. Epub 2018 May 16.

24.

Barriers to insurance coverage for transgender patients.

Learmonth C, Viloria R, Lambert C, Goldhammer H, Keuroghlian AS.

Am J Obstet Gynecol. 2018 Sep;219(3):272.e1-272.e4. doi: 10.1016/j.ajog.2018.04.046. Epub 2018 May 5.

PMID:
29733842
25.

Alcohol research with transgender populations: A systematic review and recommendations to strengthen future studies.

Gilbert PA, Pass LE, Keuroghlian AS, Greenfield TK, Reisner SL.

Drug Alcohol Depend. 2018 May 1;186:138-146. doi: 10.1016/j.drugalcdep.2018.01.016. Epub 2018 Mar 10. Review.

26.

Primary Care Provider Practices and Perceptions Regarding HPV Vaccination and Anal Cancer Screening at a Boston Community Health Center.

Apaydin KZ, Fontenot HB, Shtasel DL, Mayer KH, Keuroghlian AS.

J Community Health. 2018 Aug;43(4):792-801. doi: 10.1007/s10900-018-0486-0.

27.

Providing Care for Lesbian, Gay, Bisexual, and Transgender Immigrants at Health Centers and Clinics.

Keuroghlian AS, McDowell MJ, Stern TA.

Psychosomatics. 2018 Mar - Apr;59(2):193-198. doi: 10.1016/j.psym.2017.10.008. Epub 2017 Oct 23. No abstract available.

PMID:
29198425
28.

Factors Associated with Gender-Affirming Surgery and Age of Hormone Therapy Initiation Among Transgender Adults.

Beckwith N, Reisner SL, Zaslow S, Mayer KH, Keuroghlian AS.

Transgend Health. 2017 Oct 1;2(1):156-164. doi: 10.1089/trgh.2017.0028. eCollection 2017.

29.

Advancing health equity for lesbian, gay, bisexual and transgender (LGBT) people through sexual health education and LGBT-affirming health care environments.

Keuroghlian AS, Ard KL, Makadon HJ.

Sex Health. 2017 Feb;14(1):119-122. doi: 10.1071/SH16145. Review.

PMID:
28160786
30.

Consideration of Clozapine and Gender-Affirming Medical Care for an HIV-Positive Person with Schizophrenia and Fluctuating Gender Identity.

Gerken AT, McGahee S, Keuroghlian AS, Freudenreich O.

Harv Rev Psychiatry. 2016 Nov/Dec;24(6):406-415. No abstract available.

PMID:
27824636
31.

Discriminatory experiences associated with posttraumatic stress disorder symptoms among transgender adults.

Reisner SL, White Hughto JM, Gamarel KE, Keuroghlian AS, Mizock L, Pachankis JE.

J Couns Psychol. 2016 Oct;63(5):509-519. Epub 2016 Feb 11.

32.

Interactions of borderline personality disorder and anxiety disorders over 10 years.

Keuroghlian AS, Gunderson JG, Pagano ME, Markowitz JC, Ansell EB, Shea MT, Morey LC, Sanislow C, Grilo CM, Stout RL, Zanarini MC, McGlashan TH, Skodol AE.

J Clin Psychiatry. 2015 Nov;76(11):1529-34. doi: 10.4088/JCP.14m09748.

PMID:
26114336
33.

The Effect of Attending Good Psychiatric Management (GPM) Workshops on Attitudes Toward Patients With Borderline Personality Disorder.

Keuroghlian AS, Palmer BA, Choi-Kain LW, Borba CP, Links PS, Gunderson JG.

J Pers Disord. 2016 Aug;30(4):567-76. doi: 10.1521/pedi_2015_29_206. Epub 2015 Jun 25.

34.

Substance use and treatment of substance use disorders in a community sample of transgender adults.

Keuroghlian AS, Reisner SL, White JM, Weiss RD.

Drug Alcohol Depend. 2015 Jul 1;152:139-46. doi: 10.1016/j.drugalcdep.2015.04.008. Epub 2015 Apr 22.

35.

Interactions of borderline personality disorder and mood disorders over 10 years.

Gunderson JG, Stout RL, Shea MT, Grilo CM, Markowitz JC, Morey LC, Sanislow C, Yen S, Zanarini MC, Keuroghlian AS, McGlashan TH, Skodol AE.

J Clin Psychiatry. 2014 Aug;75(8):829-34. doi: 10.4088/JCP.13m08972.

PMID:
25007118
36.

Out on the street: a public health and policy agenda for lesbian, gay, bisexual, and transgender youth who are homeless.

Keuroghlian AS, Shtasel D, Bassuk EL.

Am J Orthopsychiatry. 2014;84(1):66-72. doi: 10.1037/h0098852.

37.

The relationship of chronic medical illnesses, poor health-related lifestyle choices, and health care utilization to recovery status in borderline patients over a decade of prospective follow-up.

Keuroghlian AS, Frankenburg FR, Zanarini MC.

J Psychiatr Res. 2013 Oct;47(10):1499-506. doi: 10.1016/j.jpsychires.2013.06.012. Epub 2013 Jul 12.

38.

Circadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work.

Keuroghlian AS, Barry AS, Weiss RD.

Am J Addict. 2012 Nov-Dec;21(6):576-7. doi: 10.1111/j.1521-0391.2012.00273.x. Epub 2012 Sep 21. No abstract available.

39.

Voluntary switching between identities in dissociative identity disorder: A functional MRI case study.

Savoy RL, Frederick BB, Keuroghlian AS, Wolk PC.

Cogn Neurosci. 2012;3(2):112-9. doi: 10.1080/17588928.2012.669750. Epub 2012 Mar 23.

PMID:
24168692
40.

Trauma, dissociation, and antiretroviral adherence among persons living with HIV/AIDS.

Keuroghlian AS, Kamen CS, Neri E, Lee S, Liu R, Gore-Felton C.

J Psychiatr Res. 2011 Jul;45(7):942-8. doi: 10.1016/j.jpsychires.2011.05.003. Epub 2011 Jun 1.

41.

Hypnotizability, posttraumatic stress, and depressive symptoms in metastatic breast cancer.

Keuroghlian AS, Butler LD, Neri E, Spiegel D.

Int J Clin Exp Hypn. 2010 Jan;58(1):39-52. doi: 10.1080/00207140903310790.

42.

Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer.

Sephton SE, Dhabhar FS, Keuroghlian AS, Giese-Davis J, McEwen BS, Ionan AC, Spiegel D.

Brain Behav Immun. 2009 Nov;23(8):1148-55. doi: 10.1016/j.bbi.2009.07.007. Epub 2009 Jul 28.

PMID:
19643176
43.

Adaptive auditory plasticity in developing and adult animals.

Keuroghlian AS, Knudsen EI.

Prog Neurobiol. 2007 Jun;82(3):109-21. Epub 2007 Apr 8. Review.

PMID:
17493738

Supplemental Content

Loading ...
Support Center